Non-White MS Patients Rarely Included in Trials

Over 25 years of clinical research, phase 3 trials of approved disease-modifying therapies for multiple sclerosis were overwhelmingly made up of White participants, new research shows.

Related Keywords

New York ,United States ,California ,Maryland ,National Harbor ,Texas ,Luisan Borrell ,Leorah Freeman ,City University Of New York ,University Of Texas At Austin ,Consortium Of Multiple Sclerosis Centers ,Dell Medical School ,Years Of Clinical Research ,Dell Medical ,Multiple Sclerosis Centers ,Southern California ,United States Black ,City University ,Multiple Sclerosis Ms ,Multiple Sclerosis ,Us ,Clinical Research ,Clinical Trials ,Linical Studies ,Racial Ethnic Disparity ,Racial Equality ,Racism In Medicine ,Physician Is Racist ,Acism In The Medical Field ,Structural Racism ,Diversity ,Social Determinants Of Health ,Social Issues ,Disease Modifying Therapy ,Mt ,Multiple Sclerosis Treatment ,Als Treatment ,Reatment Of Multiple Sclerosis ,Treatment ,